Skip to content
Recall Observatory FDA recall evidence

Drug product

Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.

D-0772-2021

July 02, 2021

Class I

Product summary

Firm
KVK-Tech, Inc.
Event
Event 88220
Status
Terminated
Classification
Class I
Quantity
1,692 bottles
Official record key
drug-enforcement:D-0772-2021

Official wording

Reason: Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

Code information: Batch # 16653A, 16654A, Exp 12/2022

Distribution pattern: Product was distributed to one distributor who may have further distributed Nationwide in the USA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Temperature abuse: the firm received customer complaints of unusual grittiness in the product.